Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 1.89% is 75% below its 5-year average of 7.71%, near the low end of its 5-year range (1.89%–30.65%).
As of the fiscal period ended Friday, October 31, 2025. 39.13% below its 12-month average of 3.10%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
1.89%
RETURN ON ASSETS (ROA) AVG TTM
3.10%
RETURN ON ASSETS (ROA) AVG 3Y
3.02%
RETURN ON ASSETS (ROA) AVG 5Y
7.71%
RETURN ON ASSETS (ROA) AVG 10Y
6.76%
RETURN ON ASSETS (ROA) AVG 15Y
5.25%
RETURN ON ASSETS (ROA) AVG 20Y
4.59%
CURRENT VS TTM AVG
-39.13%
CURRENT VS 3Y AVG
-37.47%
CURRENT VS 5Y AVG
-75.50%
CURRENT VS 10Y AVG
-72.04%
CURRENT VS 15Y AVG
-64.02%
CURRENT VS 20Y AVG
-58.85%
SECTOR MEDIAN · HEALTHCARE
4.91%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-61.51%
vs the sector median at left
The Cooper Companies, Inc.
Market Cap
$14.21B
Return on Assets (ROA)
1.89%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$15.04B
Return on Assets (ROA)
10.16%
TTM Avg
7.10%
3Y Avg
8.43%
5Y Avg
7.35%
Market Cap
$12.81B
Return on Assets (ROA)
6.81%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$12.79B
Return on Assets (ROA)
-5.53%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$12.42B
Return on Assets (ROA)
2.01%
TTM Avg
2.19%
3Y Avg
1.89%
5Y Avg
3.83%
Market Cap
$16.18B
Return on Assets (ROA)
23.89%
TTM Avg
21.05%
3Y Avg
19.32%
5Y Avg
16.45%
Market Cap
$11.74B
Return on Assets (ROA)
10.14%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$11.63B
Return on Assets (ROA)
-2.39%
TTM Avg
-0.94%
3Y Avg
2.58%
5Y Avg
3.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $14.21B | 1.89% | 3.10% | 3.02% | 7.71% |
| Solventum Corporation (SOLV)vs › | $15.04B | 10.16% | 7.10% | 8.43% | 7.35% |
| Align Technology, Inc. (ALGN)vs › | $12.81B | 6.81% | 6.68% | 6.69% | 12.75% |
| Baxter International Inc. (BAX)vs › | $12.79B | -5.53% | -3.64% | -1.62% | 0.47% |
| DaVita Inc. (DVA)vs › | $15.68B | 4.47% | 4.84% | 4.27% | 4.56% |
| Revvity, Inc. (RVTY)vs › | $12.42B | 2.01% | 2.19% | 1.89% | 3.83% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.18B | 23.89% | 21.05% | 19.32% | 16.45% |
| Insulet Corp. (PODD)vs › | $11.74B | 10.14% | 10.65% | 7.37% | 5.11% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.63B | -2.39% | -0.94% | 2.58% | 3.75% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 5.92% | 7.45% | 8.56% | 11.79% |
ROA
1.9%
ROE
2.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-10-31 | 3.02% |
| 2024-10-31 | 3.19% |
| 2023-10-31 | 2.52% |
| 2022-10-31 | 3.36% |
| 2021-10-31 | 30.65% |
| 2020-10-31 | 3.54% |
| 2019-10-31 | 7.44% |
| 2018-10-31 | 2.29% |
| 2017-10-31 | 7.67% |
| 2016-10-31 | 6.12% |
| 2015-10-31 | 4.56% |
| 2014-10-31 | 6.05% |
| 2013-10-31 | 9.44% |
| 2012-10-31 | 8.44% |
| 2011-10-31 | 6.68% |
| 2010-10-31 | 4.47% |
| 2009-10-31 | 3.94% |
| 2008-10-31 | 2.53% |
| 2007-10-31 | -0.44% |
| 2006-10-31 | 2.82% |
| 2005-10-31 | 4.21% |
| 2004-10-31 | 11.44% |
| 2003-10-31 | 9.75% |
| 2002-10-31 | 8.56% |
| 2001-10-31 | 9.36% |
| 2000-10-31 | 8.98% |
| 1999-10-31 | 8.78% |
| 1998-10-31 | 13.45% |
| 1997-10-31 | 17.91% |
| 1996-10-31 | 16.13% |
